Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Does Your Drug Expertise Include Clinical Pharmaceutics?

Author(s):  Newton David W

Issue:  May/Jun 2016 - Volume 20, Number 3
View All Articles in Issue

Page(s):  202-206

Does Your Drug Expertise Include Clinical Pharmaceutics? Page 1
Does Your Drug Expertise Include Clinical Pharmaceutics? Page 2
Does Your Drug Expertise Include Clinical Pharmaceutics? Page 3
Does Your Drug Expertise Include Clinical Pharmaceutics? Page 4
Does Your Drug Expertise Include Clinical Pharmaceutics? Page 5

Download in electronic PDF format for $75

Abstract:  Whose job is it to protect patients from harm from drug instabilities and incompatibilities and other aspects of clinical pharmaceutics? Pharmacists are better educated via multiple required general and organic chemistry prerequisite and professional curricula medicinal chemistry and pharmaceutics courses. Therefore, no healthcare professional other than pharmacists are nicknamed drug experts or are better formally educated to master drug chemistry in the bottle (i.e., injection stability and compatibility/incompatibility clinical pharmaceutics) as a prerequisite for drug administration to cause safe and effective drug chemistry in the body (i.e., clinical pharmacokinetics and pharmacology). To be a patient’s last chance for safe and effective drug therapy requires terminal control by pharmacists over identification, retrieval, preparation, labeling, and counseling or instruction of drug therapy.

Related Keywords: David W. Newton, BS Pharm, PhD, FAPhA, Professor, drug safety, stability, compatibility, incompatibility, Trissel's Handbook on Injectable Drugs, clinical pharmaceutics, drug information, applied clinical chemistry, drug admixtures, drug interactions, salts of organic drugs, refrigeration, temperature, medicinal chemistry


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
Sep/Oct 2016
Pg. 389-396

Basics of Compounding: Clinical Studies
Allen Loyd V Jr
Nov/Dec 2002
Pg. 443-447

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel
, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021
Pg. 446-462

Book Reviews: Veterinary Drug Handbook: Client Information Edition
Reed-Kane Dana
May/Jun 2005
Pg. 173

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Drug Compatibility and Stability in Dextrose vs Saline
Newton David W
May/Jun 2011
Pg. 190-192

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 230-233

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Return to Top